4 days Where Will AbbVie Be in 5 Years?The Motley Fool

Most pharmaceutical businesses are slow-moving by nature due to the lengthy amount of time it takes to develop a new medicine, and AbbVie (NYSE: ABBV) is no exception. Nonetheless, the next five years will likely see it growing faster than the last fiv…

·